Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -5 of 5 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 5/1/1990


1.		Phase III Placebo-Controlled Randomized Study of IGIV pH 4.25 in the Prophylaxis of Infections in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma Who Have Experienced Recurrent Infections (Summary Last Modified 05/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				18 and over								CBM-532-8705 NCI-V88-0583

Last Modified: 8/10/2006


2.		Phase II Study of Unrelated Bone Marrow Transplantation with Cyclophosphamide and Total-Body Irradiation in Patients With Hematologic Malignancies/Disorders

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				17 to 60				Other				TUHSC-2803 NCI-V96-0950, NCT00002809

Last Modified: 5/3/2007


3.		Phase II Pilot Feasibility Study of High-Dose Chemotherapy with CTX/VP-16 or CTX/ARA-C/AZQ, Total-Body Irradiation, and HLA-Mismatched Bone Marrow Transplantation in the Treatment of Aggressive Malignancy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 5				NCI				NCI-86-C-12A NCI-T86-0057N, T86-0057

Last Modified: 3/1/1988


4.		Phase II Study of Prophylactic Immunoglobulin in Patients Undergoing Autologous or Allogeneic Bone Marrow Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				1 to 60								GUMC-BMT-8 NCI-V87-0320

Last Modified: 2/1/1990


5.		Pilot Study of High-Dose Continuous Infusional Intravenous Immunoglobulin in Patients Undergoing Bone Marrow Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care, Treatment				Closed				any age								GUMC-12089 NCI-V89-0237

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute